Anti–Vascular Endothelial Growth Factor Drugs Compared With Panretinal Photocoagulation for the Treatment of Proliferative Diabetic Retinopathy: A Cost-Effectiveness Analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Anti–Vascular Endothelial Growth Factor Drugs Compared With Panretinal Photocoagulation for the Treatment of Proliferative Diabetic Retinopathy: A Cost-Effectiveness Analysis

Published:2024-07 Issue:7 Volume:27 Page:907-917
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Walton Matthew,Bojke Laura,Simmonds Mark,Walker Ruth,Llewellyn Alexis,Fulbright Helen,Dias Sofia,Stewart Lesley A.,Rush Tom,Steel David H.,Lawrenson John G.,Peto Tunde,Hodgson Robert

Funder

National Institute for Health Research

Publisher

Elsevier BV

Reference36 articles.

1. Estimating the current and future costs of type 1 and type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs;Hex;Diabet Med,2012

2. Recent trends in vision impairment certifications in England and Wales;Rahman;Eye (Lond),2020

3. Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis;Teo;Ophthalmology,2021

4. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group;Ophthalmology,1991

5. Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation;Royle;Health Technol Assess,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP